Clinical Trial Update: Effects of EPA and Vitamin E on Leptin, Adiponectin and Enzymatic Antioxidants in Type 2 DM [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports results on the effects of EPA and vitamin E on leptin, adiponectin, and enzymatic antioxidants in individuals with Ty…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Eicosapentaenoic acid (EPA) (eicosapentaenoic acid)
• Vitamin E (tocopherol)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED